Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

TRK reported for 6 months of 2023 by RAS

7/28/23 TORS

Kaluga Sales Company reported for 6 months of 2023 by RAS

7/28/23 KLSB

Sakhalinenergo reported for 6 months of 2023 by RAS

7/28/23 SLEN

DIOD reported for 6 months of 2023 by RAS

7/28/23 DIOD

Magadanenergo reported for 6 months of 2023 by RAS

7/28/23 MAGE

Rosseti North-West reported for 6 months of 2023 by RAS

7/28/23 MRKZ

Acron reported for 6 months of 2023 by RAS

7/28/23 AKRN

Rosseti Moscow Region reported for 6 months of 2023 by RAS

7/28/23 MSRS

KuibyshevAzot reported for 6 months of 2023 by RAS

7/28/23 KAZT

Samolet's profit in first half of the year decreased by 5%

7/28/23 SMLT